Evidence map›Paper›PMID 32168371›Full record

ArticleBrain : a journal of neurology2020

A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants.

Javier A López-Rivera, Eduardo Pérez-Palma, Joseph Symonds, Amanda S Lindy, Dianalee A McKnight, Costin Leu, Sameer Zuberi, Andreas Brunklaus, Rikke S Møller, Dennis Lal

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Prevalence of Phelan McDermid Syndrome Estimated To Be ~1:7300 Using a Multisource Model.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Jordan syndrome due toTranslational pediatrics · 2025
    Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Javier A López-RiveraDepartment of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, USA.
Eduardo Pérez-PalmaGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, USA.
Joseph SymondsThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
Amanda S LindyGeneDx, Gaithersburg, MD, USA.
Dianalee A McKnightGeneDx, Gaithersburg, MD, USA.
Costin LeuGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, USA.
Sameer ZuberiThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
Andreas BrunklausThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
Rikke S MøllerDepartment of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Dennis LalDepartment of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, USA.

Funding

Clinical genetics of drug-resistant epilepsy with focal cortical dysplasiaR01NS117544 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DENNIS LAL, Costin Leu · 2021 to 2026
$3.4M
Molecular Medicine Training ProgramT32GM088088 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI SMITH, JONATHAN D · 2011 to 2020
$1.7M
NIGMS NIH HHS T32 GM088088NINDS NIH HHS R01 NS117544
6 · The paper itself

Abstract

A large fraction of rare and severe neurodevelopmental disorders are caused by sporadic de novo variants. Epidemiological disease estimates are not available for the vast majority of these de novo monogenic neurodevelopmental disorders because of phenotypic heterogeneity and the absence of large-scale genomic screens. Yet, knowledge of disease incidence is important for clinicians and researchers to guide health policy planning. Here, we adjusted a statistical method based on genetic data to predict, for the first time, the incidences of 101 known de novo variant-associated neurodevelopmental disorders as well as 3106 putative monogenic disorders. Two corroboration analyses supported the validity of the calculated estimates. First, greater predicted gene-disorder incidences positively correlated with larger numbers of pathogenic variants collected from patient variant databases (Kendall's τ = 0.093, P-value = 6.9 × 10-6). Second, for six of seven (86%) de novo variant associated monogenic disorders for which epidemiological estimates were available (SCN1A, SLC2A1, SALL1, TBX5, KCNQ2, and CDKL5), the predicted incidence estimates matched the reported estimates. We conclude that in the absence of epidemiological data, our catalogue of 3207 incidence estimates for disorders caused by de novo variants can guide patient advocacy groups, clinicians, researchers, and policymakers in strategic decision-making.

Indexed as

Genetic VariationHumansIncidenceNeurodevelopmental DisordersRare Diseasesautismepilepsyincidenceneurodevelopmental disorder

Identifiers

PMID32168371
PMCPMC7174049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.